DPL, Commonwealth Fund and Health Affairs release policy papers

Health Affairs
March 21, 2018

Culminating a collaboration with the Drug Pricing Lab and The Commonwealth Fund, Health Affairs has released the final three policy papers that delve into key prescription drug pricing issues. In combination with the companion primer series, the three Policy Options papers address fundamental challenges in the drug pricing landscape and lay out policy proposals presented for each issue.  The papers are accessible at the following links:

Improving The Affordability Of Specialty Drugs By Addressing Patients’ Out-Of-Pocket Spending

Promoting Competition To Address Pharmaceutical Prices

Policy Strategies For Aligning Price And Value For Brand-Name Pharmaceuticals